Lv51
1298 积分 2021-12-23 加入
VLS-101, a ROR1-Targeting Antibody-Drug Conjugate, Demonstrates a Predictable Safety Profile and Clinical Efficacy in Patients with Heavily Pretreated Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma
14天前
已完结
VLS-101, a ROR1-Targeting Antibody-Drug Conjugate, Demonstrates a Predictable Safety Profile and Clinical Efficacy in Patients with Heavily Pretreated Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma
14天前
已关闭
VLS-101, a ROR1-Targeting Antibody-Drug Conjugate, Demonstrates a Predictable Safety Profile and Clinical Efficacy in Patients with Heavily Pretreated Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma
14天前
已关闭
Protein aggregation – Mechanisms, detection, and control
17天前
已完结
Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation
1个月前
已完结
Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages
2个月前
已完结
Evaluations of the Performance of the Aβ42/Aβ40 Ratios, p-Tau181 and p-Tau217 Assays in Alzheimer’s Disease Plasma (P7-9.002)
3个月前
已关闭
Data from CD58 Alterations Govern Antitumor Immune Responses by Inducing PDL1 and IDO in Diffuse Large B-Cell Lymphoma
3个月前
已完结
ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion
3个月前
已完结
New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress
4个月前
已关闭
皖公网安备34019202002308
